<?xml version="1.0" encoding="UTF-8"?>
<ref id="cit0039">
 <label>39.</label>
 <mixed-citation publication-type="journal">
  <string-name>
   <surname>Lai</surname>
   <given-names>-C-C</given-names>
  </string-name>, 
  <string-name>
   <surname>Shih</surname>
   <given-names>T-P</given-names>
  </string-name>, 
  <string-name>
   <surname>Ko</surname>
   <given-names>W-C</given-names>
  </string-name>, 
  <string-name>
   <surname>Tang</surname>
   <given-names>H-J</given-names>
  </string-name>, 
  <string-name>
   <surname>Hsueh</surname>
   <given-names>P-R</given-names>
  </string-name>. 
  <article-title>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges</article-title>. 
  <source>
   <italic toggle="yes">Int J Antimicrob Agents</italic>
  </source>. 
  <year>2020</year>;
  <volume>55</volume>(
  <issue>3</issue>):
  <fpage>105924</fpage>. doi:
  <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2020.105924</pub-id>
  <pub-id pub-id-type="pmid">32081636</pub-id>
 </mixed-citation>
</ref>
